MURRAY RICHARD /CA/
Insider CIK 1242935 · JNCE CEO and President, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| JNCE Jounce Therapeutics, Inc. | D To issuer deriv | 2023-05-03 | 2023-05-04 | 150,000 | — | $0 | 0 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | D To issuer deriv | 2023-05-03 | 2023-05-04 | 175,000 | — | $0 | 0 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | D To issuer deriv | 2023-05-03 | 2023-05-04 | 15,000 | — | $0 | 0 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | D To issuer deriv | 2023-05-03 | 2023-05-04 | 150,010 | — | $0 | 0 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | D To issuer deriv | 2023-05-03 | 2023-05-04 | 665,169 | — | $0 | 0 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | D To issuer deriv | 2023-05-03 | 2023-05-04 | 165,954 | — | $0 | 0 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | D To issuer deriv | 2023-05-03 | 2023-05-04 | 125,010 | — | $0 | 0 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | D To issuer deriv | 2023-05-03 | 2023-05-04 | 200,000 | — | $0 | 0 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | D To issuer deriv | 2023-05-03 | 2023-05-04 | 182,926 | — | $0 | 0 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | D To issuer deriv | 2023-05-03 | 2023-05-04 | 54,200 | — | $0 | 0 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | U Tender | 2023-05-03 | 2023-05-04 | 188,778 | — | $0 | 1 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | S Sale | 2023-04-04 | 2023-04-06 | 39,228 | $1.85 | $72.6K | 188,779 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | S Sale | 2023-01-10 | 2023-01-11 | 24,879 | $1.12 | $27.9K | 228,007 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | S Sale | 2023-01-09 | 2023-01-11 | 20,191 | $1.10 | $22.2K | 252,886 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | A Award deriv | 2022-02-01 | 2022-02-03 | 175,000 | — | $0 | 175,000 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | A Award | 2022-02-01 | 2022-02-03 | 87,500 | — | $0 | 273,077 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | S Sale | 2022-01-10 | 2022-01-11 | 23,924 | $6.65 | $159.1K | 185,577 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | S Sale | 2022-01-07 | 2022-01-11 | 13,370 | $7.30 | $97.6K | 209,501 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | A Award | 2021-02-03 | 2021-02-03 | 7,500 | — | $0 | 222,871 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | A Award deriv | 2021-02-01 | 2021-02-03 | 15,000 | — | $0 | 15,000 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | A Award deriv | 2021-02-01 | 2021-02-03 | 150,000 | — | $0 | 150,000 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | A Award | 2021-02-01 | 2021-02-03 | 75,000 | — | $0 | 215,371 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | M Exercise deriv | 2021-01-21 | 2021-01-25 | 33,518 | — | $0 | 665,169 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | S Sale | 2021-01-21 | 2021-01-25 | 33,518 | $12.06 | $404.2K | 140,371 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | M Exercise | 2021-01-21 | 2021-01-25 | 33,518 | $0.48 | $16.1K | 173,889 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | M Exercise deriv | 2021-01-20 | 2021-01-20 | 16,482 | — | $0 | 698,687 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | M Exercise | 2021-01-20 | 2021-01-20 | 16,482 | $0.48 | $7.9K | 156,853 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | S Sale | 2021-01-20 | 2021-01-20 | 16,482 | $12.04 | $198.4K | 140,371 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | M Exercise deriv | 2021-01-19 | 2021-01-20 | 40,000 | — | $0 | 715,169 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | M Exercise | 2021-01-19 | 2021-01-20 | 40,000 | $0.48 | $19.2K | 180,371 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | S Sale | 2021-01-19 | 2021-01-20 | 40,000 | $9.59 | $383.6K | 140,371 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | M Exercise deriv | 2021-01-15 | 2021-01-20 | 30,000 | — | $0 | 755,169 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | M Exercise | 2021-01-15 | 2021-01-20 | 30,000 | $0.48 | $14.4K | 170,371 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | S Sale | 2021-01-15 | 2021-01-20 | 30,000 | $8.54 | $256.2K | 140,371 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | S Sale | 2021-01-08 | 2021-01-11 | 11,816 | $7.00 | $82.7K | 140,371 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | S Sale | 2021-01-07 | 2021-01-11 | 10,183 | $6.76 | $68.8K | 152,187 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | A Award deriv | 2020-02-03 | 2020-02-04 | 150,010 | — | $0 | 150,010 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | A Award | 2020-02-03 | 2020-02-04 | 75,010 | — | $0 | 162,370 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | S Sale | 2020-01-07 | 2020-01-10 | 7,150 | $7.78 | $55.6K | 87,360 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | M Exercise deriv | 2019-12-23 | 2019-12-26 | 40,000 | $0.48 | $19.2K | 785,169 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | S Sale | 2019-12-23 | 2019-12-26 | 40,000 | $8.37 | $334.8K | 94,510 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | M Exercise | 2019-12-23 | 2019-12-26 | 40,000 | $0.48 | $19.2K | 134,510 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | A Award deriv | 2019-02-01 | 2019-02-05 | 125,010 | — | $0 | 125,010 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | A Award | 2019-02-01 | 2019-02-05 | 62,510 | — | $0 | 94,510 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | M Exercise deriv | 2018-09-06 | 2018-09-07 | 32,000 | — | $0 | 825,169 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | M Exercise | 2018-09-06 | 2018-09-07 | 32,000 | $0.48 | $15.4K | 32,000 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | M Exercise deriv | 2018-03-08 | 2018-03-12 | 16,334 | — | $0 | 857,169 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | M Exercise | 2018-03-08 | 2018-03-12 | 16,334 | $0.48 | $7.8K | 16,334 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | S Sale | 2018-03-08 | 2018-03-12 | 16,334 | $25.10 | $410.0K | 0 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | M Exercise deriv | 2018-03-05 | 2018-03-07 | 16,334 | — | $0 | 873,503 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | S Sale | 2018-03-05 | 2018-03-07 | 4,234 | $22.06 | $93.4K | 0 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | S Sale | 2018-03-05 | 2018-03-07 | 12,100 | $21.21 | $256.6K | 4,234 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | M Exercise | 2018-03-05 | 2018-03-07 | 16,334 | $0.48 | $7.8K | 16,334 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | A Award deriv | 2018-02-01 | 2018-02-05 | 200,000 | — | $0 | 200,000 | SEC↗ |